Temozolomide treatment induces lncRNA MALAT1 in an NF-кB and p53 co-dependent manner in glioblastoma

Alkylating chemotherapy is a central component of the management of glioblastoma (GBM). Among the factors that regulate the response to alkylation damage, NF-кB acts to both promote and block cytotoxicity. In this study, we used genome-wide expression analysis in U87 GBM to identify NF-кB-dependent...

詳細記述

保存先:
書誌詳細
出版年:Cancer Res
主要な著者: Voce, David J., Bernal, Giovanna M., Wu, Longtao, Crawley, Clayton D., Zhang, Wei, Mansour, Nassir M., Cahill, Kirk E., Szymura, Szymon J., Uppal, Abhineet, Raleigh, David R., Spretz, Ruben, Nunez, Luis, Larsen, Gustavo, Khodarev, Nikolai N., Weichselbaum, Ralph R., Yamini, Bakhtiar
フォーマット: Artigo
言語:Inglês
出版事項: 2019
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC6522287/
https://ncbi.nlm.nih.gov/pubmed/30940658
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/0008-5472.CAN-18-2170
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料